Leave your email to stay updated

Richard B. Rosen

Belinda B and Gerald G Pierce Distinguished Professor of Ophthalmology,
Icahn School of Medicine at Mount Sinai
Vice Chair and Director of Ophthalmology Research
Retina Service Chief, Mount Sinai Health System,
Surgeon Director, New York Eye and Ear Infirmary of Mount Sinai
President, New York Eye and Ear Infirmary Ophthalmology Associates, PC
Honorary Professor of Applied Optics, Dept of Applied Physics, University of Kent, Canterbury, UK

Bio

Dr. Rosen is the Belinda and Gerald Pierce Distinguished Chair of Ophthalmology and Professor of Ophthalmology at the Icahn School of Medicine at Mount Sinai. He is Chief of Retina of the Mount Sinai Health System and Retina Fellowship Director, as well as Vice Chairman, Director of Ophthalmology Research, and Surgeon Director at the New York Eye and Ear Infirmary. He is also Honorary Professor in Applied Optics at the University of Kent in Canterbury, UK., where he was awarded an Honorary Doctorate in Medical Physics. Dr. Rosen received his bachelor’s degree in psychology and anthropology at the University of Michigan and his MD from the University of Miami School of Medicine. Dr. Rosen’s research interests include new treatments for macular degeneration and diabetic retinopathy, innovations in diagnostic retinal imaging, and vitreoretinal surgical instrumentation. He helped pioneer the introduction of multimodal enface OCT/SLO, championed Adaptive Optics SLO Imaging for clinical applications at, pioneered quantitative capillary density mapping for OCT angiography, and is currently developing cellular imaging using clinical OCT along with robotic tools for vitreoretinal surgery.

With the University of Kent and Ophthalmic Technologies (OTI), he helped develop the first multimodal enface OCT/SLO instruments to clinical care along with integrated ICG Angiography, and OCT/SLO Microperimetry. His Advanced Retinal Imaging Laboratory has contributed to translational research into Ultrasound, Macular Pigment Densitometry, Retinal and Choroidal Blood Flow Monitoring, Retinal Oximetry and Metabolic Imaging, and Clinical Microscopy. With Dr. Dan-Ning Hu, director of the NYEE Ocular Cell Culture laboratory, he has also been actively involved in RPE studies of melatonin and zeaxanthin and their role in AMD, malignancy and most recently hydroxychloroquine toxicity. Dr. Rosen has served as PI for numerous industry-sponsor clinical trial and is a Co-PI on several NEI grants including its Audacious Goals program.

With Drs. Joseph Carroll, Alfredo Dubra, and Toco Chui he built the David Marrus Adaptive Optics Imaging facility at the New York Eye and Ear Infirmary, which provides Single Cell Retinal Imaging Diagnostics for patients and clinical studies in the metropolitan region. Innovative tools for measuring retinal capillary dynamics, developed in the lab, have become the standard for quantitative analysis of OCT Angiography. Dr. Rosen has authored more than 200 articles in peer-reviewed journals, 30 book chapters, 7 books, and is cited more than 9000 times. He is recipient of the AAO’s Lifetime Achievement Award, is a Lifetime member of the Pan American Association of Ophthalmology, a Gold Fellow of ARVO, the Macula Society’s Paul Henkind Award, and the Founder’s Award from the Atlantic Coast Retina Club. He has served on Executive Boards of the American Society of Ocular Trauma, Retinal Physician and Ophthalmic Lasers, Surgery and Imaging, and multiple committees of the American Academy of Ophthalmology, the Association for Research in Vision and Ophthalmology and the American Society for Retina Specialists

Education

Undergraduate College: University of Michigan, Ann Arbor

Medical School: University of Miami School of Medicine

Internship – Internal Medicine: Mount Sinai Medical Center, Miami Beach, Florida

Residency – Ophthalmology: New York Eye and Ear Infirmary

Fellowship – Retina / Vitreous Surgery: New York Eye and Ear Infirmary

Disclosures

Scientific Advisory

Optovue (Visionix) – Consultant, Intellectual Property, Research support
Opticology – Intellectual Property
OD~OS – Consultant
Allergan – Consultant
Boehringer Ingelheim – Consultant, Investigator
SERI-SNEC Incubator- Member of Scientific Advisory Board
Astellas – Consultant
Genentech-Roche – Research Support
Nano Retina – Consultant, Investigator
Regeneron – Investigator, Consultant
Guardion Health- Scientific Advisory Board
CellView- Medical Advisory Board
Topcon Medical – Research support
OcuSciences – Research support
Lumithera – Consultant, Investigator
Intalight- Research Support
Avant- Founder

 

Research Support

Marrus Family Foundation,
Wise Family Foundation,
Lowenstein Foundation,
New York Eye and Ear Chairman’s Research Fund,
New York Eye and Ear Infirmary Foundation
Dennis Gierhart Foundation,
Geraldine Violett Fund,
J Millbank Foundation
NEI U01 EY025477-01, R01EY027301
Optovue (Visonix)
Topcon
Ocusciences
Intalight